Studies have revealed that the concentrations of sIL-2R, IL-10, and IL-17a in patients with ALCL at the time of diagnosis are significantly higher than those in patients with B-NHL and ALCL patients in remission (21). This evidence concerns the gene IL17A and non-Hodgkin lymphoma.